Smith & Nephew SNATS, Inc. (NYSE:SNN) is reporting third quarter earnings results on Thursday 29th October 2020, after market close.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 5,344.00 million ~ $ 5,395.00 million
Click Here For More Historical Outlooks Of Smith & Nephew SNATS, Inc.
Stock Performance
Shares of Smith & Nephew SNATS, Inc. traded low $ -1.58 or -4.24 percent on Wednesday, reaching $ 35.65 with volume of 360.00 thousand shares. Smith & Nephew SNATS, Inc. has traded high as $ 36.27 and has cracked $ 35.59 on the downward trend
According to the previous trading day, closing price of $ 35.65, representing a 42.81 % increase from the 52 week low of $ 26.07 and a 28.76 % decrease over the 52 week high of $ 52.26.
The company has a market capital of $ 15.56 billion and is part of the Healthcare sector and Medical Devices industry.
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. It also provides arthroscopic enabling technologies for healthcare providers comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue.